
- /
- Supported exchanges
- / HM
- / DY2.HM
DENTSPLY INTL (DY2 HM) stock market data APIs
DENTSPLY INTL Financial Data Overview
There is no Profile data available for DY2.HM.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get DENTSPLY INTL data using free add-ons & libraries
Get DENTSPLY INTL Fundamental Data
DENTSPLY INTL Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DENTSPLY INTL News

DENTSPLY SIRONA (XRAY) Retains Wellspect Business Citing Greater Value for Shareholders
DENTSPLY SIRONA recently decided to retain its subsidiary Wellspect Healthcare, believing in its potential for greater value generation. This, alongside the decision to enhance operational efficiency ...


Dentsply Sirona Retains Wellspect Following Strategic Review
Dentsply Sirona XRAY recently concluded that retaining the Wellspect business portfolio is likely to create more value for its stockholders compared to other strategic alternatives. CEO Dan Scavilla e...

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives
DENTSPLY SIRONA Inc. Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company CHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DENTSP...

3 Reasons to Avoid XRAY and 1 Stock to Buy Instead
Over the past six months, Dentsply Sirona’s shares (currently trading at $14.70) have posted a disappointing 8.4% loss, well below the S&P 500’s 15.5% gain. This might have investors contemplating...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.